KASL clinical practice guidelines for management of chronic hepatitis B
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yim, Hyung Joon | - |
dc.contributor.author | Kim, Ji Hoon | - |
dc.contributor.author | Park, Jun Yong | - |
dc.contributor.author | Yoon, Eileen L. | - |
dc.contributor.author | Park, Hana | - |
dc.contributor.author | Kwon, Jung Hyun | - |
dc.contributor.author | Sinn, Dong Hyun | - |
dc.contributor.author | Lee, Sae Hwan | - |
dc.contributor.author | Lee, Jeong-Moon | - |
dc.contributor.author | Lee, Hyun Woong | - |
dc.date.available | 2020-11-02T06:35:42Z | - |
dc.date.issued | 2019-06 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/1986 | - |
dc.format.extent | 67 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한간학회 | - |
dc.title | KASL clinical practice guidelines for management of chronic hepatitis B | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3350/cmh.2019.1002 | - |
dc.identifier.scopusid | 2-s2.0-85072085762 | - |
dc.identifier.wosid | 000472600100001 | - |
dc.identifier.bibliographicCitation | Clinical and Molecular Hepatology, v.25, no.2, pp 93 - 159 | - |
dc.citation.title | Clinical and Molecular Hepatology | - |
dc.citation.volume | 25 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 93 | - |
dc.citation.endPage | 159 | - |
dc.type.docType | Review | - |
dc.identifier.kciid | ART002473125 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.subject.keywordPlus | TENOFOVIR DISOPROXIL FUMARATE | - |
dc.subject.keywordPlus | SERUM ALANINE AMINOTRANSFERASE | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA RISK | - |
dc.subject.keywordPlus | ANTIGEN-POSITIVE PATIENTS | - |
dc.subject.keywordPlus | VIRUS HBV REACTIVATION | - |
dc.subject.keywordPlus | ORTHOTOPIC LIVER-TRANSPLANTATION | - |
dc.subject.keywordPlus | SPONTANEOUS HBEAG SEROCONVERSION | - |
dc.subject.keywordPlus | MAGNETIC-RESONANCE ELASTOGRAPHY | - |
dc.subject.keywordPlus | PEGYLATED INTERFERON ALPHA-2A | - |
dc.subject.keywordPlus | STEM-CELL TRANSPLANTATION | - |
dc.subject.keywordAuthor | Chronic hepatitis B | - |
dc.subject.keywordAuthor | Treatment | - |
dc.subject.keywordAuthor | KASL guidelines | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.